We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Primary Care

Journal Scan / Research · July 13, 2021

SLGT2 Inhibitors vs Sulfonylureas in Type 2 Diabetes

JAMA internal medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA internal medicine
Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes
JAMA Intern Med 2021 Jun 28;[EPub Ahead of Print], Y Xie, B Bowe, AK Gibson, JB McGill, G Maddukuri, Z Al-Aly

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading